RADIOIMMUNOSCINTIGRAPHY WITH IN-111 LABELED MONOCLONAL-ANTIBODY FRAGMENTS (F(AB')2 BW 431/31) AGAINST CEA - RADIOLABELLING, ANTIBODY KINETICS AND DISTRIBUTION, FINDINGS IN TUMOR AND NON-TUMOR PATIENTS

被引:18
|
作者
BARES, R
FASS, J
TRUONG, S
BUELL, U
SCHUMPELICK, V
机构
关键词
D O I
10.1097/00006231-198909000-00002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:627 / 641
页数:15
相关论文
共 45 条
  • [41] SPECIFIC AND NONSPECIFIC IMMUNOASSAYS TO DETECT HAMA AFTER ADMINISTRATION OF INDIUM-111-LABELED OV-T 3 F(AB')2 MONOCLONAL-ANTIBODY TO PATIENTS WITH OVARIAN-CANCER
    MASSUGER, LFAG
    THOMAS, CMG
    SEGERS, MFG
    CORSTENS, FHM
    VERHEIJEN, RHM
    KENEMANS, P
    POELS, LG
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (11) : 1958 - 1963
  • [42] Biodistribution and planar gamma camera imaging of 123I- and 131I-labeled F(ab′)2 and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor
    Burvenich, Ingrid J. G.
    Schoonooghe, Steve
    Blanckaert, Peter
    Bacher, Klaus
    Vervoort, Liesbet
    Coene, Elisabeth
    Mertens, Nico
    De Vos, Filip
    Slegers, Guido
    NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (03) : 257 - 265
  • [43] Phase-I/II radio-immunotherapy study with iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′)2 in patients with non-resectable liver metastases from colorectal cancer
    Ychou, M
    Pelegrin, A
    Faurous, P
    Robert, B
    Saccavini, JC
    Guerreau, D
    Rossi, JF
    Fabbro, M
    Buchegger, F
    Mach, JP
    Artus, JC
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (04) : 615 - 619
  • [44] DIFFERENTIAL TISSUE DISTRIBUTION OF I-131 LABELED WHOLE AND F(AB')2 FRAGMENTS OF THE MONOCLONAL-ANTIBODY (MOAB) 225.28S TO A HUMAN HIGH MOLECULAR-WEIGHT MELANOMA ASSOCIATED ANTIGEN (HMW-MAA) IN VOLUNTEERS WITHOUT MELANOMA
    CALLEGARO, L
    FERRONE, S
    PLASSIO, G
    DOVIS, M
    MARIANI, G
    BURAGGI, GL
    BONIOLO, A
    ROSA, U
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1983, 8 (05): : A18 - A18
  • [45] Comparison of tumor targeting with 111In-labeled humanized anti-CD22 (111In hLL2) monoclonal antibody (MAB) scanning and 18FDG-PET in patients with relapsed non-Hodgkin's lymphoma.
    Matthies, A
    Cortés-Blanco, A
    Juweid, M
    Pourdehnad, M
    Goldenberg, DM
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 276P - 276P